Updated:
Primer Ventures
Venture Capital Empowering Life Science Innovations & Visionaries | Primer Ventures is a life science venture capital fund based in Silicon Valley,...
Primer Ventures
Venture Capital Empowering Life Science Innovations & Visionaries | Primer Ventures is a life science venture capital fund based in Silicon Valley, focusing on early-stage (Series pre-A, A, B) investments in the fields of life science tools and innovative therapeutics. Our mission is to empower visionary entrepreneurs to transform advanced science and technology into groundbreaking products, therapies and services.
General information
Firm type
Venture Capital
Year founded
2023
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Principals
Alexis Ji
Founding Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Primer Ventures?
Alexis Ji, the Founding Partner, is the sole investment decision-maker identified by the firm. She brings two decades of experience, including a partner role at Illumina Ventures and prior positions at WuXi Ventures and ARCH Venture Partners, plus biotech R&D experience at Merck, Roche, and Life Technologies. No other investment professionals or partners are listed on the firm's website.
How does Primer Ventures source proprietary deal flow?
The firm's deal flow appears to depend on Alexis Ji's network, built over a six-year tenure as a partner at Illumina Ventures and earlier roles at ARCH Venture Partners and WuXi Ventures. With no other named investment professionals or disclosed institutional LP relationships, sourcing likely runs through her personal relationships with scientific founders, academic labs, and co-investors established during those prior funds.
Is there a stated AUM or fund size for Primer Ventures?
No. Primer Ventures does not publicly disclose assets under management, total committed capital, or fund-vehicle sizes. Any AUM figure is unavailable from primary sources and cannot be verified.
What investment stages does Primer Ventures typically target?
The firm focuses on early-stage companies in the life-science tools and therapeutics sectors. Its stated mandate covers breakthrough innovations at an early stage, aiming to accelerate development toward market, though it does not specify a typical check size or precise stage cutoff (seed, Series A, or Series B).
Which sectors does Primer Ventures explicitly avoid?
The firm does not publish a negative list, but its stated focus is exclusively life-science tools and therapeutics. There is no indication of interest in digital health services, medical devices outside its tools domains, or non-healthcare technology sectors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: